Dergiler / art / 2020 / Cilt: 35 - Sayı: 2

Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus

Dergi
art
Sayfa
239–246
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Multivariate logistic regressionresults suggested that elderly age (≥60 years), long illness duration (1-10 years, ≥10 years), Raynaud’s phenomenon, and tachypnea were statisticallyassociated with the occurrence of ILD in SLE patients.Conclusion: Chinese SLE patients who possessed the factors that were statistically associated with ILD, namely, elderly age (≥60 years old), longillness duration (≥1 years), Raynaud’s phenomenon, and tachypnea, were recommended to be monitored for the possibility of ILD.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aims to evaluate the frequency and clinical and laboratory features of interstitial lung disease (ILD) in Chinese patients withsystemic lupus erythematosus (SLE) and to evaluate the association of ILD with the clinical features.Patients and methods: The study included 505 SLE patients (64 males, 441 females; mean age 35.3±15.3 years; range, 14 to 87 years) who werecategorized into two groups as 449 patients without ILD and 56 patients with ILD based on evidence obtained from high-resolution computedtomography images.
📊
Temel Bulgular & Veri:The demographic data, clinical and laboratory findings, SLE disease activity index score, and Systemic Lupus InternationalCollaborating Clinics/American College of Rheumatology Damage Index of all patients were also recorded and statistically analyzed.Results: The ILD frequency in patients with SLE was 11.1%.
💡
Sonuç & Katkı:Multivariate logistic regressionresults suggested that elderly age (≥60 years), long illness duration (1-10 years, ≥10 years), Raynaud’s phenomenon, and tachypnea were statisticallyassociated with the occurrence of ILD in SLE patients.Conclusion: Chinese SLE patients who possessed the factors that were statistically associated with ILD, namely, elderly age (≥60 years old), longillness duration (≥1 years), Raynaud’s phenomenon, and tachypnea, were recommended to be monitored for the possibility of ILD.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This study aims to evaluate the frequency and clinical and laboratory features of interstitial lung disease (ILD) in Chinese patients withsystemic lupus erythematosus (SLE) and to evaluate the association of ILD with the clinical features.Patients and methods: The study included 505 SLE patients (64 males, 441 females; mean age 35.3±15.3 years; range, 14 to 87 years) who werecategorized into two groups as 449 patients without ILD and 56 patients with ILD based on evidence obtained from high-resolution computedtomography images. The demographic data, clinical and laboratory findings, SLE disease activity index score, and Systemic Lupus InternationalCollaborating Clinics/American College of Rheumatology Damage Index of all patients were also recorded and statistically analyzed.Results: The ILD frequency in patients with SLE was 11.1%. Compared to the group of SLE patients without ILD, the group of SLE patients withILD possessed the following statistical differences: elderly age, longer illness duration, lower level of anti-double-stranded deoxyribonucleic acid,and higher level of serum complement 3, increased ratios of Raynaud’s phenomenon, moist rales and tachypnea. Multivariate logistic regressionresults suggested that elderly age (≥60 years), long illness duration (1-10 years, ≥10 years), Raynaud’s phenomenon, and tachypnea were statisticallyassociated with the occurrence of ILD in SLE patients.Conclusion: Chinese SLE patients who possessed the factors that were statistically associated with ILD, namely, elderly age (≥60 years old), longillness duration (≥1 years), Raynaud’s phenomenon, and tachypnea, were recommended to be monitored for the possibility of ILD.

🔖

Bu Makaleye Atıf Yap

CHEN, Y., WANG, Y., CHEN, X., LIANG, H., YANG, X. (2020). Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus. art, Cilt: 35 - Sayı: 2, 239–246. https://ajindex.com/articles/351651

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med 2004;25:549-59
  2. Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN. Cyclophosphamide for connective tissue diseaseassociated interstitial lung disease. Cochrane Database Syst Rev 2018;1:CD010908
  3. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010;138:251-6
  4. Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, et al. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation. Ann Rheum Dis 2015;74:1772-7
  5. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48
  6. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidencebased guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824
  7. Gutsche M, Rosen GD, Swigris JJ. Connective Tissue Disease-associated Interstitial Lung Disease: A review. Curr Respir Care Rep 2012;1:224-32
  8. Saketkoo LA, Matteson EL, Brown KK, Seibold JR, Strand V. Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease. J Rheumatol 2011;38:1514-8
  9. Garcia D, Young L. Lymphocytic interstitial pneumonia as a manifestation of SLE and secondary Sjogren’s syndrome. BMJ Case Rep 2013;2013. pii: bcr2013009598
  10. Miyagi R, Ideguchi H, Soga T, Sakamoto K, Niino H, Shiina T, et al. Interstitial pneumonia as an initial manifestation in a patient with late-onset SLE. Int J Rheum Dis 2014;17:813-6
  11. Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 2017;56:1945-61
  12. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86
  13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH.